SAGE Therapeutics
About:
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Website: http://www.sagerx.com
Twitter/X: sagebiotech
Top Investors: OrbiMed, Biogen, ARCH Venture Partners, Foresite Capital, Third Rock Ventures
Description:
SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.
$2.7B
$50M to $100M
Cambridge, Massachusetts, United States
2010-01-01
careers(AT)sagerx.com
Douglas Covey, Steven Paul
501-1000
2020-11-27
Public
© 2025 bioDAO.ai